Jgp Global Gestao De Recursos Ltda. Sage Therapeutics, Inc. Transaction History

Jgp Global Gestao De Recursos Ltda.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$70.65 - $96.76 $184,961 - $253,317	-2,618 Closed	0 $0
Q4 2020 Jan 27, 2021	BUY	$58.41 - $89.06 $152,917 - $233,159	2,618 New	2,618 $226,000
Q1 2020 May 07, 2020	SELL	$26.15 - $77.24 $95,316 - $281,539	-3,645 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$60.18 - $154.77 $2,647 - $6,809	44 Added 1.22%	3,645 $263,000
Q3 2019 Oct 29, 2019	BUY	$140.29 - $189.96 $9,960 - $13,487	71 Added 2.01%	3,601 $505,000
Q2 2019 Jul 19, 2019	SELL	$157.85 - $183.09 $308,912 - $358,307	-1,957 Reduced 35.67%	3,530 $646,000
Q1 2019 Apr 24, 2019	BUY	$89.33 - $163.65 $45,022 - $82,479	504 Added 10.11%	5,487 $873,000
Q4 2018 Jan 23, 2019	BUY	$81.94 - $139.71 $408,307 - $696,174	4,983 New	4,983 $477,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.